Keith Flaherty
Lua error in package.lua at line 80: module 'strict' not found.
Keith Flaherty is director of Developmental Therapeutics at the Massachusetts General Hospital Cancer Center and associate professor of medicine at Harvard Medical School.[1] He was previously a professor of medicine at the University of Pennsylvania. He is known for his research on targeted therapies for cancer, and in particular for his work on the melanoma drug vemurafenib.[2][3][4][5] In 2013, Massachusetts General Hospital partnered with AstraZeneca to partner Flaherty's research into developing a formula to identify vulnerabilities of tumors with AstraZeneca's library of drugs.[6]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references> tag; parameter "group" is allowed only.
<references />, or <references group="..." />- ↑ Keith T. Flaherty, MD - Massachusetts General Hospital, Boston, MA
- ↑ Target Cancer - A Roller Coaster Chase for a Cure - Series - NYTimes.com
- ↑ Target Cancer - After Long Fight, Melanoma Drug Gives Sudden Reprieve - Series - NYTimes.com
- ↑ Target Cancer - A Drug Trial Cycle - Recovery, Relapse, Reinvention - Series - NYTimes.com
- ↑ Inhibition of Mutated, Activated BRAF in Metastatic Melanoma — NEJM
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
